Here, I provide an overview of the NKL-code in normal hematopoiesis and instance mechanisms of deregulation and oncogenic functions of selected NKL genes in hematologic cancers. This evidence concerns the gene GLIS2 and hematopoietic and lymphoid cell neoplasm.